Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share ...

Illumina is one of Mainboard-listed Venture Corporation’s major customers. Illumina’s shares have fallen some 26.4% over the ...

The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

The "most promising areas" are integrated device manufacturers (IDMs) and high-end outsourced assembly and test (OSAT) ...

SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session ...